Paul Tudor Jones Uni Qure N.V. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Uni Qure N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 23,653 shares of QURE stock, worth $105,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,653
Previous 25,953
8.86%
Holding current value
$105,492
Previous $175,000
30.29%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding QURE
# of Institutions
149Shares Held
34.1MCall Options Held
1.07MPut Options Held
603K-
Vestal Point Capital, LP New York, NY4.73MShares$21.1 Million2.03% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.09MShares$13.8 Million1.03% of portfolio
-
683 Capital Management, LLC New York, NY1.98MShares$8.81 Million0.88% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$8.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.52MShares$6.77 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $208M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...